Logo

Roche's Termination of Epigenomics Alliance Topped Most-Read GenomeWeb News Stories Last Week

Dec 18, 2006
NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 15.
 
1. Roche Abandons Biomarker-Development Alliance With Epigenomics (from Dec. 15)
 
2. White House to Consider NIH Bill That Would Reform Budget, Spending, Oversight, and Growth (Dec. 12)
 
3. Seeing Market Shift, Invitrogen to Exclusively Distribute Blue Heron's Synthetic Gene Products (Dec. 12)
 
4. New Company in London Will Help Forge Alliances Between Genomic Industry, Academia (Dec. 13)
 
5. IntegraGen Opens Subsidiary in US; Former Roche Exec Will Be CEO (Dec. 14)
Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.